Nova Biomedical is a manufacturer of innovative analytical instruments and consumables essential for patient treatment guidance and biotechnology therapeutic development. The company focuses on delivering high-quality decision support tools for healthcare providers. They emphasize a strong commitment to improving patient care on a global scale. Nova Biomedical's founding shareholders will remain in a consulting capacity after the merger.

Nova Biomedical

Advanced Instruments is a global provider of scientific and analytical instruments for the biotechnology, clinical, and food and beverage industries. For more than 65 years, the company's innovations have helped organizations improve quality of results, achieve reliable outcomes, and increase workplace productivity. Advanced Instruments has a diverse portfolio of products, including freezing point osmometers, cerebrospinal fluid cell counters, anaerobic jar systems, cryoscopes, pasteurization test systems, and testing standards and controls. For more information, visit www.aicompanies.com

https://www.aicompanies.com/

Advanced Instruments

Advanced Instruments has announced a definitive agreement to acquire Nova Biomedical, leading to a merger that will create a global life science tools platform under the Nova Biomedical name. The transaction aims to enhance the combined company’s capabilities in the biopharma and clinical markets. Closing is expected in the third quarter of 2025, pending regulatory approval.

Advanced Instruments to acquire Nova Biomedical

Advanced Instruments to acquire Nova Biomedical

Company Info